haematology

Hemlibra now available for self injection at home

The haemophilia A treatment emicizumab (Hemlibra) will be available from 2 November via national blood supply arrangements for use at home under the supervision of a Haemophilia Treatment Centre. As previously announced, the product will be available “to prevent or reduce the frequency of bleeding in severe or moderate haemophilia A patients without inhibitors, and ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic